Alan R. Katz to Prostatic Neoplasms
This is a "connection" page, showing publications Alan R. Katz has written about Prostatic Neoplasms.
Connection Strength
0.735
-
Katz A, Kang J. Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study. Radiat Oncol. 2014 Jan 01; 9:1.
Score: 0.265
-
Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol. 2010 Feb 01; 10:1.
Score: 0.202
-
Katz A, Katz A, Burchill C. Androgen therapy: testing before prescribing and monitoring during therapy. Can Fam Physician. 2007 Nov; 53(11):1936-42.
Score: 0.173
-
Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2019 02 01; 2(2):e188006.
Score: 0.094